← Back to Search

Dietary Supplement

Nitric Oxide Supplement for Primary Ciliary Dyskinesia

N/A
Recruiting
Led By Ricardo A Mosquera, MD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Control Group: patients with no known chronic lung disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline,after beet juice consumption(2 hours after consumption)
Awards & highlights

Study Summary

This trial tests a dietary supplement to see if it can improve lung function and cilia movement in normal people and those with Primary ciliary dyskinesia.

Who is the study for?
This trial is for adults aged 18-99 with Primary Ciliary Dyskinesia (PCD) and healthy controls without chronic lung disease. It's not suitable for those with bleeding disorders, beet allergies, other pulmonary conditions like cystic fibrosis, or recent nasal surgeries/infections.Check my eligibility
What is being tested?
The study tests the effects of 'Beet-it Juice', a dietary supplement high in nitric oxide, on nasal and exhaled NO levels, ciliary beat frequency using video microscopy, and overall lung function through spirometry in PCD patients compared to healthy individuals.See study design
What are the potential side effects?
While not explicitly stated here, potential side effects may include reactions related to beet consumption such as red-colored urine/stools, low calcium levels if taken excessively, kidney damage when consumed in large amounts over time.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any chronic lung diseases.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after beet juice consumption(2 hours after consumption)
This trial's timeline: 3 weeks for screening, Varies for treatment, and after beet juice consumption(2 hours after consumption) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in nasal FeNO as measured by using the NIOX MINO® Airway Inflammation Monitor
Change in nasal NO as measured by a chemiluminescence analyzer
Secondary outcome measures
Change in ciliary beat frequency as measured using high-speed video-microscopy (HSVM)
Change in lung function as measured by spirometry

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: PCD GroupExperimental Treatment1 Intervention
Group II: Control GroupPlacebo Group1 Intervention

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
904 Previous Clinical Trials
320,940 Total Patients Enrolled
Ricardo A Mosquera, MDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
3 Previous Clinical Trials
423 Total Patients Enrolled

Media Library

Beet-it Juice (Dietary Supplement) Clinical Trial Eligibility Overview. Trial Name: NCT04489472 — N/A
Primary Ciliary Dyskinesia Research Study Groups: PCD Group, Control Group
Primary Ciliary Dyskinesia Clinical Trial 2023: Beet-it Juice Highlights & Side Effects. Trial Name: NCT04489472 — N/A
Beet-it Juice (Dietary Supplement) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04489472 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~0 spots leftby May 2024